Featured companies in Pharma

Get access to the Seedtable database with +15,000 companies (266 from Pharma)
Causaly
Causaly causaly.com
93

Featured

Biomedical research discovery tool.

  • Latest Funding

    $60 Million · Series B

  • Employees

    51 to 100

  • Investors

    Marathon VC, Pentech Ventures, ICONIQ Growth, Index Ventures

  • Business Model

    B2B, SAAS

  • Industries

    Health Tech, AI, Biotech, Pharma

  • Locations

    London

  • Contact

    •••••@causaly.com
    Unlock contact info

Bactolife
Bactolife bactolife.com
79

Featured

Producer of gut health binding proteins.

  • Latest Funding

    $33 Million · Series A

  • Employees

    1 to 10

  • Investors

    Bill & Melinda Gates Foundation, Novo A/S

  • Business Model

    B2B

  • Industries

    Biotech, Pharma

  • Locations

    Copenhagen

  • Contact

    •••••@bactolife.com
    Unlock contact info

Hemab
Hemab hemab.com
75

Featured

Treatments for genetic bleeding disorders.

  • Latest Funding

    $140 Million · Series B

  • Employees

    1 to 10

  • Investors

    HealthCap, Novo A/S

  • Business Model

    B2B

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma

  • Locations

    Copenhagen

  • Contact

    •••••@hemab.com
    Unlock contact info

Pharma by location

List of 69 top tech companies in Pharma

Get access to the Seedtable database with +15k companies (266 from Pharma)
Pear Bio pearbio.com
68

Cancer treatment predictor software.

  • Latest Funding

    $14 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Hoxton Ventures, Octopus Ventures, Fly Ventures

  • Contact

    •••••@pearbio.com
    Unlock contact info

ReViral reviral.co.uk
68

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

  • Latest Funding

    $44 Million · Series C

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Andera Partners, Novo A/S

  • Contact

    •••••@reviral.co.uk
    Unlock contact info

SafeHeal safeheal.com
68

SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications.

  • Latest Funding

    $48 Million

  • Industries

    Health Tech, Hardware, Pharma, Manufacturing

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Sofinnova Partners

  • Contact

    •••••@safeheal.com
    Unlock contact info

Castor EDC castoredc.com
64

Cloud-based clinical data platform.

  • Latest Funding

    $45 Million · Series B

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Amsterdam

  • Employees

    101 to 250

  • Business Model

    B2B, SAAS

  • Investors

    Eight Roads Ventures, Inkef Capital

  • Contact

    •••••@castoredc.com
    Unlock contact info

Epsilogen epsilogen.com
64

Immuno-oncology company treats cancer with antibodies.

  • Latest Funding

    $42 Million

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Epidarex Capital, AlbionVC, Novartis Venture Fund

  • Contact

    •••••@epsilogen.com
    Unlock contact info

Kayentis kayentis.com
64

Data capture for clinical trials.

  • Latest Funding

    $2.4 Million · Seed

  • Industries

    Health Tech, Pharma, Data and Analytics

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B, SAAS

  • Investors

    Bpifrance

  • Contact

    •••••@kayentis.com
    Unlock contact info

Manual manual.co
64

Manual provides diagnostic tools and testing to help patients make health-related decisions.

  • Latest Funding

    $30 Million · Series A

  • Industries

    Health Tech, Fashion, Pharma, Mobile, Ecommerce

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2C

  • Investors

    Felix Capital, Cherry Ventures, FJ Labs

  • Contact

    •••••@manual.co
    Unlock contact info

Precirix precirix.com
64

Manufacturer of radio-immunotherapeutic drugs for cancer patients.

  • Latest Funding

    $88 Million · Series B

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma, Manufacturing

  • Locations

    Brussels

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Gimv, Forbion Capital Partners, BioMedPartners, HealthCap, V-Bio Ventures, Novo A/S, Inkef Capital

  • Contact

    •••••@precirix.com
    Unlock contact info

Step Pharma step-ph.com
64

Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).

  • Latest Funding

    $41 Million · Series B

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    AGORANOV, Bpifrance, Idinvest Partners, Hadean Ventures

  • Contact

    •••••@step-ph.com
    Unlock contact info

Iktos iktos.ai
64

AI drug discovery platform.

  • Latest Funding

    $16 Million · Series A

  • Industries

    Pharma

  • Locations

    Paris

  • Employees

    11 to 50

  • Investors

    M Ventures

  • Contact

    •••••@iktos.ai
    Unlock contact info

Ariceum Therapeutics ariceum-therapeutics.com
62

Diagnosis and treatment of hard-to-treat cancers.

  • Latest Funding

    $25 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Berlin

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Andera Partners, HealthCap, Pureos Bioventures, Earlybird Venture Capital

  • Contact

    •••••@ariceum-therapeutics.com
    Unlock contact info

Noema Pharma noemapharma.com
62

Clinical-stage central nervous system (CNS) technology.

  • Latest Funding

    $110 Million · Series B

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Basel

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Forbion Capital Partners, BioMedPartners, Sofinnova Partners

  • Contact

    •••••@noemapharma.com
    Unlock contact info

Qualifyze qualifyze.com
62

Qualifyze making supply chains in life sciences more transparent and secure at affordable costs.

  • Latest Funding

    $12 Million · Series A

  • Industries

    AI, Pharma, Business Intelligence

  • Locations

    Frankfurt

  • Employees

    11 to 50

  • Business Model

    B2B, MARKETPLACE

  • Investors

    H14, HV Capital, Cherry Ventures, Coparion, APX

  • Contact

    •••••@qualifyze.com
    Unlock contact info

Enterome enterome.com
59

Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.

  • Latest Funding

    $43 Million · Series F

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma

  • Locations

    Paris

  • Employees

    51 to 100

  • Business Model

    B2B

  • Investors

    Omnes Capital, Nestlé Health Science, Seventure Partners

  • Contact

    •••••@enterome.com
    Unlock contact info

Ermium Therapeutics ermium.com
59

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.

  • Latest Funding

    $6 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Fountain Healthcare Partners

  • Contact

    •••••@ermium.com
    Unlock contact info

Gesynta Pharma gesynta.se
59

Developer of therapies for treating chronic inflammatory conditions.

  • Latest Funding

    $21 Million · Series C

  • Industries

    Health Tech, Pharma

  • Locations

    Stockholm

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Hadean Ventures, Industrifonden

  • Contact

    •••••@gesynta.se
    Unlock contact info

HMNC Brain Health hmnc-brainhealth.com
59

HMNC Brain Health is a precision medicine pioneer in psychiatry based in Munich.

  • Latest Funding

    $14 Million

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma, Manufacturing

  • Locations

    Munich

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    ALSTIN Capital

  • Contact

    •••••@hmnc-brainhealth.com
    Unlock contact info

Lyphe group LYPHEGROUP.com
59

Lyphe group is a reliable supplier of medical cannabis care and medicine.

  • Latest Funding

    $6.2 Million · Series A

  • Industries

    Health Tech, Agritech, Pharma, Manufacturing, Cannabis

  • Locations

    London

  • Employees

    51 to 100

  • Business Model

    B2B

  • Investors

    Leafy Tunnel

  • Contact

    •••••@lyphegroup.com
    Unlock contact info

Myricx Pharma myricxpharma.com
59

Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors.

  • Latest Funding

    $6 Million · Seed

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Sofinnova Partners

  • Contact

    •••••@myricxpharma.com
    Unlock contact info

Peptone peptone.io
59

We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.

  • Latest Funding

    $40 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma, Manufacturing

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Hoxton Ventures, Bessemer Venture Partners

  • Contact

    •••••@peptone.io
    Unlock contact info

Qubit Pharmaceuticals qubit-pharmaceuticals.com
59

Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.

  • Latest Funding

    $17 Million · Seed

  • Industries

    Health Tech, Biotech, Pharma, Manufacturing

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    XAnge, Quantonation

  • Contact

    •••••@qubit-pharmaceuticals.com
    Unlock contact info

Measurlabs measurlabs.com
59

Testing and certifications platform for any material, product or chemical.

  • Latest Funding

    $2.7 Million · Seed

  • Industries

    Biotech, Pharma

  • Locations

    Helsinki

  • Employees

    11 to 50

  • Investors

    VentureFriends, Lifeline Ventures

  • Contact

    •••••@measurlabs.com
    Unlock contact info

Anjarium Biosciences anjarium.com
56

Gene therapy research to tackle genetic diseases.

  • Latest Funding

    $60 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Zürich

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Gimv

  • Contact

    •••••@anjarium.com
    Unlock contact info

Cardior Pharmaceuticals cardior.de
56

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

  • Latest Funding

    $76 Million

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Hanover

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    BioMedPartners, Inkef Capital, Hadean Ventures, Coparion, High-Tech Gründerfonds

  • Contact

    •••••@cardior.de
    Unlock contact info

Emergence Therapeutics emergencetx.com
56

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

  • Latest Funding

    $99 Million

  • Industries

    Health Tech, Biotech, Pharma, Fitness, Manufacturing

  • Locations

    Duisburg

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Hadean Ventures, High-Tech Gründerfonds

  • Contact

    •••••@emergencetx.com
    Unlock contact info

F2G f2g.com
56

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

  • Latest Funding

    $70 Million

  • Industries

    Health Tech, Biotech, Pharma, Genetics

  • Locations

    Manchester

  • Employees

    251 to 500

  • Business Model

    B2B

  • Investors

    Forbion Capital Partners, Sofinnova Partners, Novo A/S

  • Contact

    •••••@f2g.com
    Unlock contact info

Healx healx.io
56

Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.

  • Latest Funding

    $56 Million · Series B

  • Industries

    Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence

  • Locations

    Cambridge

  • Employees

    51 to 100

  • Business Model

    B2B, SAAS

  • Investors

    Balderton Capital, Amadeus Capital, Atomico, btov Partners

  • Contact

    •••••@healx.io
    Unlock contact info

ImCheck Therapeutics imchecktherapeutics.com
56

ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.

  • Latest Funding

    $100 Million

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma

  • Locations

    Marseille

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Gimv, Eurazeo, Andera Partners, Earlybird Venture Capital

  • Contact

    •••••@imchecktherapeutics.com
    Unlock contact info

ImmunOs Therapeutics immunostherapeutics.com
56

ImmunOs Therapeutics is a clinical-stage biotechnology company.

  • Latest Funding

    $74 Million

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Zürich

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Gimv, BioMedPartners, Lightspeed Venture Partners

  • Contact

    •••••@immunostherapeutics.com
    Unlock contact info

Osler Diagnostics oslerdiagnostics.com
56

Lab-quality diagnostics for anyone, anywhere, at any time.

  • Latest Funding

    $85 Million · Series C

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma

  • Locations

    Oxford

  • Employees

    51 to 100

  • Business Model

    B2B

  • Investors

    Oxford Science Enterprises

  • Contact

    •••••@oslerdiagnostics.com
    Unlock contact info

Oxford Nanopore Technologies nanoporetech.com
56

Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.

  • Latest Funding

    $280 Million

  • Industries

    Health Tech, Biotech, Pharma, Robotics, Manufacturing, Genetics

  • Locations

    Oxford

  • Employees

    251 to 500

  • Business Model

    B2B

  • Investors

    Wellington Management

  • Contact

    •••••@nanoporetech.com
    Unlock contact info

SkyCell skycell.ch
56

SkyCell developed the next generation of temperature controlled logistics containers for the pharmaceutical industry.

  • Industries

    AI, Pharma, Mobility & Transportation

  • Locations

    Zürich

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    MVM Life Science Partners

  • Contact

    •••••@skycell.ch
    Unlock contact info

Vivasure Medical vivasuremedical.com
56

Medical device company developing a closure device for vascular access procedures.

  • Latest Funding

    $32 Million · Series D

  • Industries

    Health Tech, Hardware, Biotech, Pharma, Manufacturing

  • Locations

    Galway

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Fountain Healthcare Partners

  • Contact

    •••••@vivasuremedical.com
    Unlock contact info

Aqemia aqemia.com
54

Drug discovery - Pharma 3.0

  • Latest Funding

    $29 Million · Series A

  • Industries

    Health Tech, AI, Biotech, Machine Learning, Pharma, Quantum Computing

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Eurazeo, Elaia

  • Contact

    •••••@aqemia.com
    Unlock contact info

CimCure cimcure.com
54

CimCure focuses on design and development of a novel class of active cancer immunotherapies.

  • Latest Funding

    $5.4 Million · Seed

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Amsterdam

  • Employees

  • Business Model

    B2B

  • Investors

    Positron Ventures

  • Contact

    •••••@cimcure.com
    Unlock contact info

Core Biogenesis corebiogenesis.com
54

Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.

  • Latest Funding

    $11 Million · Series A

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma, Manufacturing

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Thia Ventures, XAnge, Entrepreneur First, Plug and Play Spain

  • Contact

    •••••@corebiogenesis.com
    Unlock contact info

Inato inato.com
54

AI-powered data collecting tool for clinical trials.

  • Latest Funding

    $20 Million · Series A

  • Industries

    Health Tech, AI, Biotech, Machine Learning, Pharma

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B, SAAS

  • Investors

    Cathay Innovation, Serena, Fly Ventures, Kima Ventures

  • Contact

    •••••@inato.com
    Unlock contact info

Muna Therapeutics munatherapeutics.com
54

Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.

  • Latest Funding

    $73 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Copenhagen

  • Employees

  • Business Model

    B2B

  • Investors

    Sofinnova Partners, V-Bio Ventures, Novo A/S, VIB

  • Contact

    •••••@munatherapeutics.com
    Unlock contact info

Pheon Therapeutics pheontx.com
54

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

  • Latest Funding

    $68 Million · Series A

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Forbion Capital Partners

  • Contact

    •••••@pheontx.com
    Unlock contact info

Actimed Therapeutics actimedtherapeutics.com
54

Developer of innovative treatment for muscle wasting disorders.

  • Latest Funding

    $6.1 Million · Series A

  • Industries

    Biotech, Pharma

  • Locations

    London

  • Employees

    1 to 10

  • Investors

    Mankind Pharma

  • Contact

    •••••@actimedtherapeutics.com
    Unlock contact info

NK:IO nk-io.com
54

Immunotherapy for the treatment of cancer.

  • Latest Funding

    $1.5 Million · Seed

  • Industries

    Biotech, Pharma

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2C

  • Investors

    Cancer Research Horizons, UK Innovation & Science Seed Fund

  • Contact

    •••••@nk-io.com
    Unlock contact info

BioVersys bioversys.com
51

Novel antiobiotic researcher to fight antimicrobial resistance.

  • Latest Funding

    $9 Million · Series C

  • Industries

    Biotech, Pharma

  • Locations

    Basel

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    AMR Action Fund

  • Contact

    •••••@bioversys.com
    Unlock contact info

Cinclus Pharma cincluspharma.com
51

Cinclus Pharma is a research based biotech company.

  • Latest Funding

    $26 Million

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Gothenburg

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    EIR Ventures

  • Contact

    •••••@cincluspharma.com
    Unlock contact info

Nucleome Therapeutics nucleome.com
51

Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases

  • Latest Funding

    $44 Million

  • Industries

    Health Tech, Biotech, Pharma, Manufacturing, Genetics

  • Locations

    Oxford

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Oxford Science Enterprises

  • Contact

    •••••@nucleome.com
    Unlock contact info

AFYX Therapeutics afyxtx.com
50

AFYX Therapeutics is a clinical stage biopharmaceutical company

  • Latest Funding

    $13 Million

  • Industries

    Health Tech, Edtech, Biotech, Pharma, Food Delivery

  • Locations

    Copenhagen

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Sofinnova Partners

  • Contact

    •••••@afyxtx.com
    Unlock contact info

AptaTargets aptatargets.com
50

Therapeutics treatment for strokes and brain injury.

  • Latest Funding

    $2.7 Million

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Madrid

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Caixa Capital Risc, Inveready

  • Contact

    •••••@aptatargets.com
    Unlock contact info

Baseimmune baseimmune.co.uk
50

Baseimmune is a biotech startup founded to create the next generation of vaccines.

  • Latest Funding

    $4.8 Million · Seed

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma, Manufacturing

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Hoxton Ventures, Cherry Ventures, Creator Fund, Maki.vc

  • Contact

    •••••@baseimmune.co.uk
    Unlock contact info

Biosyntia biosyntia.com
50

Biosyntia is a biotech startup within synthetic biology and metabolic engineering.

  • Latest Funding

    $12 Million · Series B

  • Industries

    Health Tech, Biotech, Pharma, Manufacturing

  • Locations

    Copenhagen

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Sofinnova Partners

  • Contact

    •••••@biosyntia.com
    Unlock contact info

Fermify fermify.org
50

Casein protein manufacturer for animal-free cheese.

  • Latest Funding

    $5 Million · Seed

  • Industries

    Foodtech, Biotech, Pharma, Manufacturing

  • Locations

    Vienna

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Climentum Capital, PUSH Ventures, BackBone Ventures

  • Contact

    •••••@fermify.org
    Unlock contact info

Ona Therapeutics ona-therapeutics.com
50

Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer.

  • Latest Funding

    $34 Million · Series A

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma

  • Locations

    Barcelona

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Ysios Capital, Asabys Partners

  • Contact

    •••••@ona-therapeutics.com
    Unlock contact info

Rappta Therapeutics rappta-therapeutics.com
50

Rappta Therapeutics is a lead-optimization stage biopharmaceutical company.

  • Latest Funding

    $11 Million · Series A

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma

  • Locations

    Helsinki

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Novartis Venture Fund, Novo A/S

  • Contact

    •••••@rappta-therapeutics.com
    Unlock contact info

Synthace synthace.com
50

Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated.

  • Latest Funding

    $35 Million · Series C

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Internet of Things

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B, SAAS

  • Investors

    Sofinnova Partners

  • Contact

    •••••@synthace.com
    Unlock contact info

Apollo Therapeutics apollotherapeutics.com
50

Portfolio of pharmaceutical research and discovery.

  • Latest Funding

    $230 Million · Series C

  • Industries

    Biotech, Pharma

  • Locations

    London

  • Employees

    1 to 10

  • Investors

    Patient Square Capital, Rock Springs Capital

  • Contact

    •••••@apollotherapeutics.com
    Unlock contact info

Abalos Therapeutics abalos-tx.com
46

Abalos Therapeutics is an Essen, Germany-based developer of novel immuno-virotherapies against cancer.

  • Latest Funding

    $50 Million

  • Industries

    Health Tech, Biotech, Pharma, Manufacturing

  • Locations

    Essen

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Seventure Partners, Coparion, High-Tech Gründerfonds

  • Contact

    •••••@abalos-tx.com
    Unlock contact info

AstriVax astrivax.com
46

AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.

  • Latest Funding

    $30 Million · Seed

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Leuven

  • Employees

  • Business Model

    B2B

  • Investors

    V-Bio Ventures

  • Contact

    •••••@astrivax.com
    Unlock contact info

Draupnir Bio draupnir.bio
46

Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.

  • Latest Funding

    $33 Million

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Aarhus

  • Employees

    10001+

  • Business Model

    B2B

  • Investors

    Inkef Capital, High-Tech Gründerfonds

  • Contact

    •••••@draupnir.bio
    Unlock contact info

GlycoEra glycoera.com
46

GlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics.

  • Latest Funding

    $49 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Zürich

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Sofinnova Partners

  • Contact

    •••••@glycoera.com
    Unlock contact info

Kither Biotech kitherbiotech.com
46

Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases

  • Latest Funding

    $20 Million · Series B

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma, Manufacturing

  • Locations

    Turin

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Claris Ventures, CDP Venture Capital Sgr

  • Contact

    •••••@kitherbiotech.com
    Unlock contact info

NMD Pharma nmdpharma.com
46

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

  • Latest Funding

    $40 Million

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Aarhus

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Novo A/S, Inkef Capital

  • Contact

    •••••@nmdpharma.com
    Unlock contact info

Sibylla Biotech sibyllabiotech.it
46

Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.

  • Latest Funding

    $23 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Trento

  • Employees

  • Business Model

    B2B

  • Investors

    V-Bio Ventures, Seroba Life Sciences, Claris Ventures, CDP Venture Capital Sgr

  • Contact

    •••••@sibyllabiotech.it
    Unlock contact info

STipe Therapeutics stipetherapeutics.com
46

STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.

  • Latest Funding

    $22 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Aarhus

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Novo A/S, Wellington Partners

  • Contact

    •••••@stipetherapeutics.com
    Unlock contact info

TargED Biopharmaceuticals targedbiopharmaceuticals.com
46

TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.

  • Latest Funding

    $44 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Utrecht

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Andera Partners, Inkef Capital, Hadean Ventures

  • Contact

    •••••@targedbiopharmaceuticals.com
    Unlock contact info

TreeFrog Therapeutics treefrog.fr
46

TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.

  • Latest Funding

    $75 Million

  • Industries

    Health Tech, Biotech, Pharma, Manufacturing

  • Locations

    Bordeaux

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    XAnge

  • Contact

    •••••@treefrog.fr
    Unlock contact info

ViCentra hellokaleido.com
46

ViCentra has developed an insulin pump for diabetes patients.

  • Latest Funding

    $73 Million

  • Industries

    Health Tech, Hardware, Pharma

  • Locations

    Utrecht

  • Employees

    11 to 50

  • Business Model

    B2C

  • Investors

    Kreos Capital, Invest-NL, Inkef Capital

  • Contact

    •••••@hellokaleido.com
    Unlock contact info

Flarin flarin.co.uk
46

Patent-protected anti-inflammatory painkiller.

  • Latest Funding

    $6.3 Million · Series A

  • Industries

    Biotech, Pharma

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2C

  • Investors

    ITV AdVentures

  • Contact

    •••••@flarin.co.uk
    Unlock contact info

1000Farmacie 1000farmacie.it
43

Online Pharmacy and Integrated Healthcare Platform

  • Latest Funding

    $15 Million · Series A

  • Industries

    Health Tech, Pharma, Sales and Marketing, Ecommerce

  • Locations

    Milan

  • Employees

    11 to 50

  • Business Model

    B2B, B2C, MARKETPLACE, SAAS

  • Investors

    P101, LIFTT, HBM Partners, Healthware Ventures

  • Contact

    •••••@1000farmacie.it
    Unlock contact info